Vidyya Medical News Service
*
Volume 5 Issue 153 Published - 14:00 UTC 08:00 EST 2-June-2003 Next Update - 14:00 UTC 08:00 EST 3-June-2003
little clear gif used for spacer
.
*

Researchers discover possible diagnosis, treatment, vaccine for mad cow, prion diseases
Research led by scientists at the University of Toronto and Caprion Pharmaceuticals have uncovered the basis for a diagnostic, immunotherapy and vaccine, providing a way to detect and treat the brain-wasting damage of infectious prions like those found in mad cow disease and its human version, Creutzfeldt-Jakob Disease.  more

*
Bevacizumab (Avastin (R)) is the first "anti-angiogenesis" drug to shrink tumors and extend survival in patients with metastatic colorectal cancer
An experimental cancer drug named bevacizumab (trade name Avastin) is the first "anti-angiogenesis" drug to prove that it can shrink tumors and extend survival in patients with metastatic colorectal cancer, according to a national clinical trial led by researchers at the Duke Comprehensive Cancer Center.  more

 


*
Test predicts which breast cancer tumors will respond to chemotherapy
Researchers at the Breast Care Center at Baylor College of Medicine and The Methodist Hospital have developed a new test to predict which breast cancer tumors will respond to chemotherapy, potentially reducing unnecessary treatment for women with breast cancer, according to data presented at the American Society of Clinical Oncology annual meeting in Chicago.  more

*
Heart problems develop sooner for childhood cancer survivors
Childhood cancer survivors may develop earlier and more extensive cardiovascular disease than doctors originally thought, according to two major clinical studies. Researchers at the University of Rochester Medical Center have found survivors as soon as five years after therapy showed signs of cardiomyopathy and premature atherosclerosis which can lead to congestive heart failure and heart attacks. more

*
Radiotherapy strategy improves survival for lung cancer patients
Study results presented at the 39th annual meeting for the American Society of Clinical Oncology (ASCO) by Chandra P. Belani, M.D., professor of medicine, University of Pittsburgh and co-director, Lung Cancer Program, University of Pittsburgh Cancer Institute (UPCI), demonstrate that a new therapeutic radiation strategy for non-small cell lung cancer (NSCLC) the most common form of the disease leads to improved survival for lung cancer patients with locally advanced disease.  more

 
little clear gif used for a space